ExoVectory and Erasmus MC join forces to develop exosome therapy for glioblastoma brain cancer

NWO has awarded project EXPERT (Exosomes to delivery cancer-killing peptides to eradicate tumor cells) to Erasmus MC, Dr. De Vrij and Dr. Luider for a 3yr project, total value € 920k, to develop therapy for glioblastoma brain cancer based on ExoVectory’s proprietary exosome delivery system. Besides Erasmus MC and ExoVectory, the project involves other participants to create unique synergy, i.e. LUMC, UMCU, Thermo Fisher Scientific, Mimetas B.V., Excytex and Stichting STOPhersentumoren.

Explore our exosome delivery technology or contact ExoVectory about partnerships and investment.